The decision to recognise UAS Labs was based on the company’s focus on R&D, innovations in quality control of probiotic products, and a broad line of condition-specific products, said F&S.
“I’m extremely proud of this award, as it is a clear recognition of our constant efforts for delivering the highest quality condition specific probiotic products to the consumers, and at the same time being able to deliver outstanding customer value,” said Dr S. K. Dash, founder and president of UAS Labs.
“Significantly, UAS Labs ensures a strong scientific validation for its products through nearly 200 studies as individual, collaborative, or sponsored efforts between the industry and academia,” said F&S senior research analyst, Dr. Kaushik. “The company has rightly identified the strategy of working with Universities to maintain a healthy pipeline of products and keep R&D costs low, thereby keeping the cost low for the consumer.”